Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |